Conference ProceedingsOPEN ACCESS

Development of organometallic ruthenium(II) anticancer (RAPTA) drugs

Chimia (2007) 61(4) 140-142
DOI: 10.2533/chimia.2007.140
7Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

The systematic development of the RAPTA family of organometallic ruthenium(II) anticancer drugs containing a monodentate 1,3,5-triaza-7- phosphatricyclo-[3.3.1.1]decane (pta) ligand and a η6-arene ligand is described. © Schweizerische Chemische Gesellschaft.

Author supplied keywords

Cite

CITATION STYLE

APA

Wee, H. A. (2007). Development of organometallic ruthenium(II) anticancer (RAPTA) drugs. In Chimia (Vol. 61, pp. 140–142). Swiss Chemical Society. https://doi.org/10.2533/chimia.2007.140

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free